

share
Anifrolumab CAS NO 1326232-46-5
Unit Price:
CAS No.:1326232-46-5
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Anifrolumab is a high-purity, human monoclonal antibody specifically designed to target the type I interferon receptor subunit 1. This product is critical for advanced pharmaceutical research and development, offering a targeted mechanism of action for modulating immune system pathways. It is primarily utilized by biopharmaceutical companies and research institutions engaged in the development of novel therapeutics for autoimmune and inflammatory diseases.
Application
- Primary active pharmaceutical ingredient (API) in biologic drug formulations.
- Reference standard for analytical method development and validation in QC laboratories.
- Critical reagent for preclinical and clinical research studies targeting type I interferon signaling.
- Key material for the development of biosimilar and bio-better therapeutic candidates.
- Used in immunological assays and diagnostic test development.
- Essential component for stability studies and formulation optimization.
Basic Information
| Product Name | Anifrolumab |
| CAS No. | 1326232-46-5 |
| Molecular Formula | C6448H9916N1704O2018S46 |
| Molecular Weight | Approx. 145 kDa |
| Synonyms | MEDI-546; Anifrolumab-fnia; Saphnelo; Anti-IFNAR1 Antibody; Type I Interferon Receptor Alpha Chain Blocker; IFNAR1 Antagonist; Immunoglobulin G1, anti-(human interferon alpha/beta receptor subunit 1) (human monoclonal MEDI-546 gamma1-chain), disulfide with human monoclonal MEDI-546 κ-chain, dimer |
| EINECS | Contact for details |
Quality Control
Our Anifrolumab is manufactured under strict quality systems. Each batch is subjected to a comprehensive battery of analytical tests to ensure identity, purity, potency, and safety, meeting the stringent requirements for pharmaceutical-grade biologics. Certificates of Analysis (COA) detailing specifications such as purity by SEC-HPLC, host cell protein content, endotoxin levels, and biological activity are provided with every shipment.
Storage
Preserve in a tightly closed container, protected from light. For long-term stability, store at -20°C to -80°C. Avoid repeated freeze-thaw cycles. The product is hygroscopic (moisture-sensitive) and should be handled under controlled conditions to maintain integrity.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white lyophilized powder or clear to slightly opalescent solution |
| Identification (HPLC/MS) | Conforms to reference standard |
| Purity (SEC-HPLC) | ≥ 98.0% (Monomer) |
| Protein Content (UV) | 95.0 - 105.0% of label claim |
| Potency (Cell-based assay) | 90.0 - 115.0% of reference |
| Endotoxin | < 1.0 EU/mg |
| Host Cell Protein | < 100 ppm |
| Sterility (where applicable) | Sterile |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Pembrolizumab CAS NO 1374853-91-4


Tuvirumab CAS NO 138660-97-6


Biciromab CAS NO 138783-13-8


Muromonab-Cd3 CAS NO 140608-64-6


Anti-Stromelysin-2 CAS NO 140610-48-6


Gendevit CAS NO 141910-80-7


Edrecolomab CAS NO 156586-89-9


Felvizumab CAS NO 167747-20-8


Faralimomab CAS NO 167816-91-3


Rovelizumab [Usan:Inn] CAS NO 197099-66-4


Teprotumumab CAS NO 1036734-93-6


Monalizumab CAS NO 1228763-95-8


Anti-Br140-Like Protein Antibody Produced In Rabbit CAS NO 1597439-92-3


Eptinezumab CAS NO 1644539-04-7


Rhumab Cd 168 CAS NO 211323-03-4


Ociperlimab CAS NO 2342597-93-5


Tadocizumab CAS NO 339086-80-5


Galiximab CAS NO 357613-77-5


Tocilizumab CAS NO 375823-41-9


Pritumumab CAS NO 499212-74-7
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






